Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George A Jacoby

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|January 16, 2013
Phylogenetic analysis of chromosomally determined qnr and related proteinsGeorge A Jacoby, David C Hooper
Cold Spring Harbor Perspectives in Medicine|July 25, 2016
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and ResistanceDavid C Hooper, George A Jacoby
The New England Journal of Medicine|January 28, 2005
The new beta-lactamasesGeorge A Jacoby, Luisa Silvia Munoz-Price
Antimicrobial Agents and Chemotherapy|December 26, 2001
Plasmid-determined AmpC-type beta-lactamasesAlain Philippon, Guillaume Arlet, George A Jacoby
International Journal of Antimicrobial Agents|January 24, 2018
Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coliLaura Vinué, David C Hooper, George A Jacoby
Microbiology Spectrum|January 14, 2015
Plasmid-mediated quinolone resistanceGeorge A Jacoby, Jacob Strahilevitz, David C Hooper
Antimicrobial Agents and Chemotherapy|January 25, 2003
Prevalence of plasmid-mediated quinolone resistanceGeorge A Jacoby, Nancy Chow, Ken B Waites
The Lancet. Infectious Diseases|September 30, 2006
The worldwide emergence of plasmid-mediated quinolone resistanceAri Robicsek, George A Jacoby, David C Hooper
Antimicrobial Agents and Chemotherapy|July 27, 2004
Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniaeGeorge A Jacoby, Debra M Mills, Nancy Chow
Antimicrobial Agents and Chemotherapy|June 10, 2015
Effect of Qnr on Plasmid Gyrase Toxins CcdB and ParEYee Gyung Kwak, George A Jacoby, David C Hooper
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|January 16, 2013
Phylogenetic analysis of chromosomally determined qnr and related proteinsGeorge A Jacoby, David C Hooper
Cold Spring Harbor Perspectives in Medicine|July 25, 2016
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and ResistanceDavid C Hooper, George A Jacoby
The New England Journal of Medicine|January 28, 2005
The new beta-lactamasesGeorge A Jacoby, Luisa Silvia Munoz-Price
Antimicrobial Agents and Chemotherapy|December 26, 2001
Plasmid-determined AmpC-type beta-lactamasesAlain Philippon, Guillaume Arlet, George A Jacoby
International Journal of Antimicrobial Agents|January 24, 2018
Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coliLaura Vinué, David C Hooper, George A Jacoby
Microbiology Spectrum|January 14, 2015
Plasmid-mediated quinolone resistanceGeorge A Jacoby, Jacob Strahilevitz, David C Hooper
Antimicrobial Agents and Chemotherapy|January 25, 2003
Prevalence of plasmid-mediated quinolone resistanceGeorge A Jacoby, Nancy Chow, Ken B Waites
The Lancet. Infectious Diseases|September 30, 2006
The worldwide emergence of plasmid-mediated quinolone resistanceAri Robicsek, George A Jacoby, David C Hooper
Antimicrobial Agents and Chemotherapy|July 27, 2004
Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniaeGeorge A Jacoby, Debra M Mills, Nancy Chow
Antimicrobial Agents and Chemotherapy|June 10, 2015
Effect of Qnr on Plasmid Gyrase Toxins CcdB and ParEYee Gyung Kwak, George A Jacoby, David C Hooper
Pageof 7